{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:18:35Z","timestamp":1777861115621,"version":"3.51.4"},"posted":{"date-parts":[[2026,4,30]]},"group-title":"In Review","reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,20]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Hepatocellular carcinoma (HCC) originates from damaged hepatocytes in chronic liver injury. Though HCC development requires oncoproteins-mediated p53 inhibition, both genetic deletion and continous activation of p53 specifically in mouse hepatocytes are shown to promote liver tumorigenesis, suggesting that chronic liver injury firstly activates p53, and p53 activity needs to be dynamically regulated for preventing hepatocarcinogenesis. Yet, it remains unaddressed how liver injury stresses trigger signaling pathways to rapidly activate p53 prior to its inactivation in a physiological setting. Two pathways, ribosomal proteins (RPs)-MDM2 and 14-3-3-MDMX, are shown to activate p53 upon stresses, and mutations of MDM2 or MDMX that may disrupt these pathways have been found in human cancers including HCC. Using our unique double knock-in (DKI) mice that contain wild-type p53 while harbor defects in these two pathways, we unveiled that basal level of p53 in DKI mice is sufficient for maintaining liver function, however, carcinogen- or unhealthy diet-induced HCC initiation is accelerated in DKI mice. The two p53-pathways are also activated in human cirrhotic livers. We futher identified a one-carbon metabolism (1CM) enzyme methylenetetrahydrofolate dehydrogenase 1 like (MTHFD1L) as the p53-suppressed player in HCC initiation. We found that MTHFD1L is upregulated in human early HCC and correlated with p53 status, and promotes mouse HCC initiation by enhancing autonomous growth and immune evasion of HCC initiating cells  (HCICs). With Nanopore RNA-m\n                  <sup>6<\/sup>\n                  A-sequencing, we unveiled that MTHFD1L fulfills these bi-functions by fueling methionine cycle that produces methyl groups to maintain the mRNA m\n                  <sup>6<\/sup>\n                  A of Snail (an HCC early tumorigenesis driver) and B2m (a light chain of MHC-I required for antigen presentation to CD8+ T) in HCICs. Our findings demonstrate that the two stress-triggered p53-pathways are crucial for preventing liver early tumorigenesis by reversing MTHFD1L upregulation-associated 1CM reprogramming and subsequent Snail and B2m mRNA-m\n                  <sup>6<\/sup>\n                  A-mediated cell autonomous growth and immune evasion.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9474831\/v1","type":"posted-content","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:56:12Z","timestamp":1777517772000},"source":"Crossref","is-referenced-by-count":0,"title":["Dual-stress-responsive-pathways prevent HCC initiation via p53 suppression of MTHFD1L-RNA m6A-elicited autonomous growth and immune evasion"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9285-7209","authenticated-orcid":false,"given":"Hua","family":"Lu","sequence":"first","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"peng","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Liao","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hoon","family":"Jung","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyue","family":"Li","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlong","family":"Liu","sequence":"additional","affiliation":[{"name":"IUPUI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Gao","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitian","family":"Zha","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Pham","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Meaderis","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Eslter","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Zhang","sequence":"additional","affiliation":[{"name":"UNC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debanjan","family":"Dhar","sequence":"additional","affiliation":[{"name":"University of California at San Diego"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5195-9420","authenticated-orcid":false,"given":"Shelya","family":"Zeng","sequence":"additional","affiliation":[{"name":"Tulane University- school of medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","first-page":"1","article-title":"Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty S","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res 2021; 149: 1\u201361.","journal-title":"Adv Cancer Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel A","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet 2022; 400: 1345\u20131362.","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","article-title":"Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling","volume":"155","author":"He G","year":"2013","unstructured":"He G, Dhar D, Nakagawa H, Font-Burgada J, Ogata H, Jiang Y et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 2013; 155: 384\u2013396.","journal-title":"Cell"},{"key":"ref4","author":"Dhar D","year":"2018","unstructured":"Dhar D, Antonucci L, Nakagawa H, Kim JY, Glitzner E, Caruso S et al. Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling. Cancer Cell 2018; 33: 1061\u20131077 e1066."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cell.2015.07.026","article-title":"Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer","volume":"162","author":"Font-Burgada J","year":"2015","unstructured":"Font-Burgada J, Shalapour S, Ramaswamy S, Hsueh B, Rossell D, Umemura A et al. Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer. Cell 2015; 162: 766\u2013779.","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/hep.28602","article-title":"Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice","volume":"64","author":"Shin S","year":"2016","unstructured":"Shin S, Wangensteen KJ, Teta-Bissett M, Wang YJ, Mosleh-Shirazi E, Buza EL et al. Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice. Hepatology 2016; 64: 1163\u20131177.","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet JM","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2021; 7: 6.","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41232-016-0025-2","article-title":"Liver regeneration and fibrosis after inflammation","volume":"36","author":"Tanaka M","year":"2016","unstructured":"Tanaka M, Miyajima A. Liver regeneration and fibrosis after inflammation. Inflamm Regen 2016; 36: 19.","journal-title":"Inflamm Regen"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1073\/pnas.1102309108","article-title":"The p53 inhibitors MDM2\/MDMX complex is required for control of p53 activity in vivo","volume":"108","author":"Huang L","year":"2011","unstructured":"Huang L, Yan Z, Liao X, Li Y, Yang J, Wang ZG et al. The p53 inhibitors MDM2\/MDMX complex is required for control of p53 activity in vivo. Proc Natl Acad Sci U S A 2011; 108: 12001\u201312006.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/cdd.2016.117","article-title":"p53 on the crossroad between regeneration and cancer","volume":"24","author":"Charni M","year":"2017","unstructured":"Charni M, Aloni-Grinstein R, Molchadsky A, Rotter V. p53 on the crossroad between regeneration and cancer. Cell Death Differ 2017; 24: 8\u201314.","journal-title":"Cell Death Differ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cell.2014.05.051","article-title":"p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer","volume":"158","author":"Tschaharganeh DF","year":"2014","unstructured":"Tschaharganeh DF, Xue W, Calvisi DF, Evert M, Michurina TV, Dow LE et al. p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. Cell 2014; 158: 579\u2013592.","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1186\/s12967-023-04799-9","article-title":"Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis","volume":"21","author":"Wang C","year":"2023","unstructured":"Wang C, Kang H, Yi Y, Ding Y, Wang F, Luo J et al. Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis. J Transl Med 2023; 21: 919.","journal-title":"J Transl Med"},{"key":"ref13","first-page":"E2414-2422","article-title":"Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation","volume":"111","author":"Liu Y","year":"2014","unstructured":"Liu Y, He Y, Jin A, Tikunov AP, Zhou L, Tollini LA et al. Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation. Proc Natl Acad Sci U S A 2014; 111: E2414-2422.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jmcb\/mjv014","article-title":"Ribosomal proteins: functions beyond the ribosome","volume":"7","author":"Zhou X","year":"2015","unstructured":"Zhou X, Liao WJ, Liao JM, Liao P, Lu H. Ribosomal proteins: functions beyond the ribosome. J Mol Cell Biol 2015; 7: 92\u2013104.","journal-title":"J Mol Cell Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/MCB.00670-13","article-title":"AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity","volume":"34","author":"He G","year":"2014","unstructured":"He G, Zhang YW, Lee JH, Zeng SX, Wang YV, Luo Z et al. AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity. Mol Cell Biol 2014; 34: 148\u2013157.","journal-title":"Mol Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ccr.2009.05.008","article-title":"Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases","volume":"16","author":"Wang YV","year":"2009","unstructured":"Wang YV, Leblanc M, Wade M, Jochemsen AG, Wahl GM. Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases. Cancer Cell 2009; 16: 33\u201343.","journal-title":"Cancer Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ccr.2010.08.007","article-title":"An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction","volume":"18","author":"Macias E","year":"2010","unstructured":"Macias E, Jin A, Deisenroth C, Bhat K, Mao H, Lindstrom MS et al. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010; 18: 231\u2013243.","journal-title":"Cancer Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/MCB.01307-06","article-title":"Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation","volume":"27","author":"Lindstrom MS","year":"2007","unstructured":"Lindstrom MS, Jin A, Deisenroth C, White Wolf G, Zhang Y. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol Cell Biol 2007; 27: 1056\u20131068.","journal-title":"Mol Cell Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"30036","DOI":"10.1074\/jbc.M604674200","article-title":"Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest","volume":"281","author":"Zhang F","year":"2006","unstructured":"Zhang F, Hamanaka RB, Bobrovnikova-Marjon E, Gordan JD, Dai MS, Lu H et al. Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J Biol Chem 2006; 281: 30036\u201330045.","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1038\/onc.2014.1","article-title":"Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer","volume":"33","author":"Brighenti E","year":"2014","unstructured":"Brighenti E, Calabrese C, Liguori G, Giannone FA, Trere D, Montanaro L et al. Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. Oncogene 2014; 33: 4396\u20134406.","journal-title":"Oncogene"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fonc.2015.00011","article-title":"Endoplasmic reticulum stress, genome damage, and cancer","volume":"5","author":"Dicks N","year":"2015","unstructured":"Dicks N, Gutierrez K, Michalak M, Bordignon V, Agellon LB. Endoplasmic reticulum stress, genome damage, and cancer. Front Oncol 2015; 5: 11.","journal-title":"Front Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1038\/sj.emboj.7600812","article-title":"ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage","volume":"24","author":"Chen L","year":"2005","unstructured":"Chen L, Gilkes DM, Pan Y, Lane WS, Chen J. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J 2005; 24: 3411\u20133422.","journal-title":"EMBO J"},{"key":"ref23","volume-title":"Hepatocellular Carcinoma","author":"Carlessi R","year":"2019","unstructured":"Carlessi R, Kohn-Gaone J, Olynyk JK, Tirnitz-Parker JEE. Mouse Models of Hepatocellular Carcinoma. In: Tirnitz-Parker JEE (ed). Hepatocellular Carcinoma: Brisbane (AU), 2019."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1590\/s0004-2803.202100000-14","article-title":"Results of Immunohistochemistry in the Differential Diagnosis of Early Hepatocellular Carcinoma and Nodules with High-Grade Dysplasia in Patients with Cirrhosis","volume":"58","author":"Coral GP","year":"2021","unstructured":"Coral GP, Branco F, Meurer R, Marcon PDS, Fontes PRO, Mattos AA. Results of Immunohistochemistry in the Differential Diagnosis of Early Hepatocellular Carcinoma and Nodules with High-Grade Dysplasia in Patients with Cirrhosis. Arq Gastroenterol 2021; 58: 82\u201386.","journal-title":"Arq Gastroenterol"},{"key":"ref25","first-page":"13","article-title":"Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis","author":"Liao Z","year":"2023","unstructured":"Liao Z, Tang C, Luo R, Gu X, Zhou J, Gao J. Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis. Diagnostics (Basel) 2023; 13.","journal-title":"Diagnostics (Basel)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1073\/pnas.1211199110","article-title":"Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice","volume":"110","author":"Momb J","year":"2013","unstructured":"Momb J, Lewandowski JP, Bryant JD, Fitch R, Surman DR, Vokes SA et al. Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice. Proc Natl Acad Sci U S A 2013; 110: 549\u2013554.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","author":"Moon H","year":"2017","unstructured":"Moon H, Ju HL, Chung SI, Cho KJ, Eun JW, Nam SW et al. Transforming Growth Factor-beta Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail. Gastroenterology 2017; 153: 1378\u20131391 e1376."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ajpath.2020.02.005","article-title":"Induction of Steatohepatitis and Liver Tumorigenesis by Enforced Snail Expression in Hepatocytes","volume":"190","author":"Miura S","year":"2020","unstructured":"Miura S, Suzuki A. Induction of Steatohepatitis and Liver Tumorigenesis by Enforced Snail Expression in Hepatocytes. Am J Pathol 2020; 190: 1271\u20131283.","journal-title":"Am J Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2021.06.008","article-title":"Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy","volume":"517","author":"Wang H","year":"2021","unstructured":"Wang H, Liu B, Wei J. Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy. Cancer Lett 2021; 517: 96\u2013104.","journal-title":"Cancer Lett"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"902820","DOI":"10.3389\/fonc.2022.902820","article-title":"Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application","volume":"12","author":"Liu S","year":"2022","unstructured":"Liu S, Huang F, Ru G, Wang Y, Zhang B, Chen X et al. Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application. Front Oncol 2022; 12: 902820.","journal-title":"Front Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.17998\/jlc.2025.08.21","article-title":"Navigating liver cancer with mouse models: a comprehensive overview of HCC experimental systems","volume":"25","author":"Kim GY","year":"2025","unstructured":"Kim GY, Kim D, Jeon J, Seo W, Park SH. Navigating liver cancer with mouse models: a comprehensive overview of HCC experimental systems. J Liver Cancer 2025; 25: 239\u2013250.","journal-title":"J Liver Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.30153","article-title":"A Transforming Growth Factor-beta and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis","volume":"69","author":"Zhang J","year":"2019","unstructured":"Zhang J, Han C, Ungerleider N, Chen W, Song K, Wang Y et al. A Transforming Growth Factor-beta and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis. Hepatology 2019; 69: 1549\u20131563.","journal-title":"Hepatology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1101\/gad.13.19.2490","article-title":"Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a","volume":"13","author":"Murphy M","year":"1999","unstructured":"Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ et al. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 1999; 13: 2490\u20132501.","journal-title":"Genes Dev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1074\/jbc.M109.079855","article-title":"Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos","volume":"285","author":"Pike ST","year":"2010","unstructured":"Pike ST, Rajendra R, Artzt K, Appling DR. Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos. J Biol Chem 2010; 285: 4612\u20134620.","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova E","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 2021; 593: 597\u2013601.","journal-title":"Nature"},{"key":"ref36","author":"Chen M","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology 2018; 67: 2254\u20132270."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.175.2.1047","article-title":"Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway","volume":"175","author":"Chen M","year":"2005","unstructured":"Chen M, Tabaczewski P, Truscott SM, Van Kaer L, Stroynowski I. Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway. J Immunol 2005; 175: 1047\u20131055.","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.0.CO;2-F","article-title":"Hepatocytes induce functional activation of naive CD8\u2009+\u2009T lymphocytes but fail to promote survival","volume":"28","author":"Bertolino P","year":"1998","unstructured":"Bertolino P, Trescol-Biemont MC, Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8\u2009+\u2009T lymphocytes but fail to promote survival. Eur J Immunol 1998; 28: 221\u2013236.","journal-title":"Eur J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1158\/1078-0432.CCR-21-1804","article-title":"Cancer Immunoediting in the Era of Immuno-oncology","volume":"28","author":"Gubin MM","year":"2022","unstructured":"Gubin MM, Vesely MD. Cancer Immunoediting in the Era of Immuno-oncology. Clin Cancer Res 2022; 28: 3917\u20133928.","journal-title":"Clin Cancer Res"},{"key":"ref40","author":"Katz SF","year":"2012","unstructured":"Katz SF, Lechel A, Obenauf AC, Begus-Nahrmann Y, Kraus JM, Hoffmann EM et al. Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation. Gastroenterology 2012; 142: 1229\u20131239 e1223."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1158\/0008-5472.CAN-21-4390","article-title":"Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis","volume":"82","author":"Makino Y","year":"2022","unstructured":"Makino Y, Hikita H, Fukumoto K, Sung JH, Sakano Y, Murai K et al. Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis. Cancer Res 2022; 82: 2860\u20132873.","journal-title":"Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ccell.2018.11.009","article-title":"The Roles of Initiating Truncal Mutations in Human Cancers: The Order of Mutations and Tumor Cell Type Matters","volume":"35","author":"Levine AJ","year":"2019","unstructured":"Levine AJ, Jenkins NA, Copeland NG. The Roles of Initiating Truncal Mutations in Human Cancers: The Order of Mutations and Tumor Cell Type Matters. Cancer Cell 2019; 35: 10\u201315.","journal-title":"Cancer Cell"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze K","year":"2015","unstructured":"Schulze K, Imbeaud S, Letouze E, Alexandrov LB, Calderaro J, Rebouissou S et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet 2015; 47: 505\u2013511.","journal-title":"Nat Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1535-6108(04)00110-2","article-title":"Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation","volume":"5","author":"Kurki S","year":"2004","unstructured":"Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D et al. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 2004; 5: 465\u2013475.","journal-title":"Cancer Cell"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/acsptsci.0c00223","article-title":"A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight","volume":"4","author":"Cuthbertson CR","year":"2021","unstructured":"Cuthbertson CR, Arabzada Z, Bankhead A, 3rd, Kyani A, Neamati N. A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight. ACS Pharmacol Transl Sci 2021; 4: 624\u2013646.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI90253","article-title":"Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma","volume":"127","author":"Lee D","year":"2017","unstructured":"Lee D, Xu IM, Chiu DK, Lai RK, Tse AP, Lan Li L et al. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. J Clin Invest 2017; 127: 1856\u20131872.","journal-title":"J Clin Invest"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2019.12.014","article-title":"Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma","volume":"72","author":"Dong LQ","year":"2020","unstructured":"Dong LQ, Peng LH, Ma LJ, Liu DB, Zhang S, Luo SZ et al. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma. J Hepatol 2020; 72: 896\u2013908.","journal-title":"J Hepatol"},{"key":"ref48","first-page":"C1190-C1205","article-title":"RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis","volume":"323","author":"Ma W","year":"2022","unstructured":"Ma W, Wu T. RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis. Am J Physiol Cell Physiol 2022; 323: C1190-C1205.","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1038\/s41467-023-40422-7","article-title":"Modulation of translational decoding by m(6)A modification of mRNA","volume":"14","author":"Jain S","year":"2023","unstructured":"Jain S, Koziej L, Poulis P, Kaczmarczyk I, Gaik M, Rawski M et al. Modulation of translational decoding by m(6)A modification of mRNA. Nat Commun 2023; 14: 4784.","journal-title":"Nat Commun"},{"key":"ref50","first-page":"172","article-title":"Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades","volume":"12","author":"Abboud Y","year":"2024","unstructured":"Abboud Y, Ismail M, Khan H, Medina-Morales E, Alsakarneh S, Jaber F et al. Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades. J Clin Transl Hepatol 2024; 12: 172\u2013181.","journal-title":"J Clin Transl Hepatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccr.2009.12.048","article-title":"Hepatocyte IKKbeta\/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation","volume":"17","author":"He G","year":"2010","unstructured":"He G, Yu GY, Temkin V, Ogata H, Kuntzen C, Sakurai T et al. Hepatocyte IKKbeta\/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 2010; 17: 286\u2013297.","journal-title":"Cancer Cell"},{"key":"ref52","author":"Chen X","year":"2023","unstructured":"Chen X, Lu Q, Zhou H, Liu J, Nadorp B, Lasry A et al. A membrane-associated MHC-I inhibitory axis for cancer immune evasion. Cell 2023; 186: 3903\u20133920 e3921."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors","volume":"9","author":"Duhen T","year":"2018","unstructured":"Duhen T, Duhen R, Montler R, Moses J, Moudgil T, de Miranda NF et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat Commun 2018; 9: 2724.","journal-title":"Nat Commun"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9474831\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9474831\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:56:20Z","timestamp":1777517780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9474831\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":53,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9474831\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,4,30]]},"subtype":"preprint"}}